Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.58 -0.04 (-6.97%)
As of: Oct 23, 2026 · 3:59 PM EDT

Bluejay Diagnostics (BJDX) Amortization of Deferred Charges (2020 - 2023)

Updated

Analysis

Bluejay Diagnostics (BJDX) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Bluejay Diagnostics 1.25 Mn -20.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 40,327.00
Mar 31, 2023 40,328.00
Jun 30, 2022 38,734.00
Mar 31, 2022 28,238.00
Dec 31, 2021 62,161.00
Jun 30, 2021 40,955.00
Mar 31, 2021 -39,185.00
Dec 31, 2020 -139,032.00
Sep 30, 2020 29,167.00
API Access

Bluejay Diagnostics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=BJDX&period=max&api_key=YOUR_API_KEY